期刊文献+

围手术期卒中患者外周血vWF及ADAMTS13检测及临床意义

Determination of VWF and ADAMTS13 in patients with perioperative stroke
下载PDF
导出
摘要 目的探讨v WF(血管性血友病因子)、ADAMTS13(血管性血友病因子裂解酶)在围手术期卒中的发生发展中所起的作用。方法收集围手术期内发生缺血性卒中的患者31例做为实验组,将实验组分为腔隙性梗死组、小面积梗死组以及大面积梗死组3个亚组。同时收集48例健康体检者做为对照组。采用酶联免疫吸附法(ELISA)检测v WF抗原、ADAMTS13抗原含量,应用残余胶原结合试验检测ADAMTS13的活性。结果 (1)实验组患者血浆中v WF抗原水平明显高于对照组(P<0.05),ADAMTS13活性水平及ADAMTS13抗原含量均明显低于对照组(P<0.05)。(2)实验组3个亚组的v WF抗原水平在大面积梗死组最高,腔隙性梗死组最低,大面积梗死组与腔隙性梗死组间差异有显著性(P<0.05)。(3)ADAMTS13抗原含量在大面积梗死组最低,腔隙性梗死组最高,3组间差异均具有显著性(均P<0.05),ADAMTS13活性水平在3组间差异无显著性(均P>0.05)。结论v WF及ADAMTS13参与了围手术期卒中的发生发展,ADAMTS13水平降低及v WF水平升高可能是围手术期卒中发生的危险因素。 Objective To investigate the roles of vWF and ADAMTS13 in the development of perioperative stroke. Methods We investigated vWF and ADAMTS13 in 31 patients with perioperative stroke and 48 healthy people in this study. 31 patients were divided into three subgroups:groups of lacunar infarction, small area of infarction, and large area of infarction. Using enzyme-linked immunosorbent assay (ELISA) to detect vWF antigen, ADAMTS13 antigen content, application of residual collagen binding assay ADAMTS13 activity. Results ( 1 ) The plasma vWF antigen levels were higher in patients with perioperative stroke compared to controls( P 〈 0.05 ) , the ADAMTS13 activity and ADAMTS13 antigen levels were lower in patients with perioperative stroke than controls ( P 〈 0.05 ). ( 2 ) VWF antigen levels were highest in large area of infarction subgroup, and lowest in lacunar infarction subgroup. There was significant difference between the large area of infarction group and the lacunar infarction group (P 〈 0.05 ). (3)ADAMTS13 antigen content was lowest in the large area of infarction group ,and was highest in the lacunar infarction group. The differences in ADAMTS13 antigen content among the three groups were significant (P 〈 0.05 ). There were no significant differences among the three groups in ADAMTS13 activity levels ( P 〉 0.05 ). Conclusion VWF and ADAMTS13 are related with the occurrence and development of perioperative stroke. High vWF and low ADAMTS13 plasma levels may be risk factors for the perioperative stroke.
作者 杜宝琦 牛平
出处 《中风与神经疾病杂志》 CAS CSCD 北大核心 2014年第12期1103-1106,共4页 Journal of Apoplexy and Nervous Diseases
关键词 围手术期卒中 内皮损伤 VWF ADAMTS13 Perioperative stroke Endothelial injury VWF ADAMTS13
  • 相关文献

参考文献14

  • 1Sarkis Morales-Vidal,Michael Schneck,Esteban Golombieski.Commonly asked questions in the management of perioperative stroke[J].Expert Rev Neurother,2013,13(2):167-175.
  • 2全国第四届脑血管病学术会议.脑卒中患者临床神经功能损伤程度评分标准及临床疗效评定标准.中华神经科杂志,1996,.
  • 3Federica V,Maurizio S,Giancarlo D,et al.Perioperative stroke risk in nonvascular surgery[J].Cerebrovasc Dis,2012,34:175-181.
  • 4Cherian P,Hankey GJ,Eikelboom JW,et al.Endothelial and platelet activation in acute ischemic stroke and its etiological subtypes[J].Stroke,2003,34(9):2132-2137.
  • 5Ohira T,Shahar E,Chambless LE,et al.Risk factors for ischemic stroke subtypes:the atherosclerosis risk in communities study[J].Stroke,2006,37(10):2493-2498.
  • 6Chauhan AK,Motto DG,Lamb CB,et al.Systemic antithrombotic effects of ADAMTS13[J].J Exp Med,2006,203(3):767-776.
  • 7Lambers ML,Goldenberg NA,Kenet G,et al.Role of reduced ADAMTS13 in arterial ischemic stroke:a pediatric cohort study[J].Ann Neurol,2013,73(1):58-64.
  • 8董宁征,刘芳,季顺东,阮长耿.急性心肌梗死和脑梗死患者血浆中ADAMTS13的测定及意义[J].中华血液学杂志,2008,29(3):161-163. 被引量:6
  • 9Zhao BQ,Chauhan AK,Canault M,et al.Von Willebrand factor-cleaving protease ADAMTS13 reduces ischemic brain injury in experimental stroke[J].Blood,2009,114(15):3329-3334.
  • 10Fujioka M,Nakano T,Hayakawa K,et al.ADAMTS13 gene deletion enhances plasma high mobility group box1 elevation and neuroinflammation in brain ischemia-reperfusion injury[J].Neurol Sci,2012,33(5):1107-1115.

二级参考文献12

  • 1刘芳,卢国元,董宁征,白霞,苏健,阮长耿.凝血酶敏感蛋白1在血栓性血小板减少性紫癜患者中的变化及与血管性血友病因子裂解蛋白酶的关系[J].中华医学杂志,2005,85(45):3190-3193. 被引量:4
  • 2刘芳,BF Hendrik,董宁征,白霞,V Karen,D Hans,阮长耿.血栓性血小板减少性紫癜患者vWF裂解蛋白酶抗原和活性的检测及意义[J].中华血液学杂志,2006,27(3):154-157. 被引量:10
  • 3各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33058
  • 4Dong JF. Structural and functional correlation of ADAMTS13.Curr Opin Hematol, 2007, 14:270-276.
  • 5Majerus EM, Anderson PJ, Sadler JE. Binding of ADAMTS13 to yon Willebrand factor. J Biol Chem, 2005, 280: 21773-21778.
  • 6Bianchi V, Robles R, Alberio L, et al. Von Willebrand factorcleaving protease (ADAMTS13) in thrombocytopenic disorders: a severely deficient activity is specific for thrombotic thrombocytopenic purpura. Blood, 2002,100:710-713.
  • 7Kokame K, Nobe Y, Kokubo Y, et al. FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay. Br J Haematol, 2005, 129:93-100.
  • 8Feys HB, Liu F, Dung N, et al. ADAMTS-13 plasma level determination uncovers antigen absence in acquired thrombotic thrombocytopenic purpura and ethnic differences. J Thromb Haemost, 2006,4:955-962.
  • 9Loof AH, van Vliet HH, Kappers-Klunne MC. Low activity of von Willebrand factor-cleaving protease is not restricted to patients suffering from thrombotic thrombocytopenic purpura. Br J Haematol, 2001,112 : 1087-1088.
  • 10Kavakli K, Canciani MT, Mannucci PM. Plasma levels of the von Willebrand factor-cleaving protease in physiological and pathological conditions in children. Pediatr Hematol Oncol, 2002,19:467- 473.

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部